Linee guida ESC per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico 2008 = Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

Authors/Task Force Members: Kenneth Dickstein (Chairperson) (Norway)*, Alain Cohen-Solal (France), Gerasimos Filippatos (Greece), John J.V. McMurray (UK), Piotr Ponikowski (Poland), Philip Alexander Poole-Wilson (UK), Anna Strömberg (Sweden), Dirk J. van Veldhuisen (The Netherlands), Dan Atar (Norway), Arno W. Hoes (The Netherlands), Andre Keren (Israel), Alexandre Mebazaa (France), Markku Nieminen (Finland), Silvia Giuliana Priori (Italy), Karl Swedberg (Sweden)

[1]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[2]  Karl Swedberg,et al.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. , 2008, European heart journal.

[3]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[4]  R. McKelvie,et al.  Diabetes, left ventricular systolic dysfunction, and chronic heart failure. , 2008, European heart journal.

[5]  G. Sutherland,et al.  Patient Selection and Echocardiographic Assessment of Dyssynchrony in Cardiac Resynchronization Therapy Crt: from Origins to Routine Clinical Practice Selection of Candidates in Crt Clinical Trials Defining Response to Therapy Contemporary Reviews in Cardiovascular Medicine , 2022 .

[6]  J. Légaré,et al.  Revascularization for ischaemic cardiomyopathy , 2008, Current opinion in cardiology.

[7]  Hans L Hillege,et al.  Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). , 2008, Archives of internal medicine.

[8]  F. Veglia,et al.  Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators: Short- and Long-Term Outcomes in a Prospective Single-Center Study , 2008, Circulation.

[9]  A. Jánosi,et al.  Rosuvastatin in older patients with systolic heart failure. , 2007, The New England journal of medicine.

[10]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[11]  K. Swedberg,et al.  Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis , 2007, European journal of heart failure.

[12]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[13]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[14]  J. Cleland,et al.  Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure , 2007, European journal of heart failure.

[15]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[16]  G. Tognoni,et al.  The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure , 2007, European journal of heart failure.

[17]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[18]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[19]  C. Specchia,et al.  The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT‐proBNP and cardiac troponin‐T , 2007, European journal of heart failure.

[20]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[21]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[22]  Jeroen J. Bax,et al.  Assessment of Myocardial Viability in Patients with Heart Failure* , 2007, Journal of Nuclear Medicine.

[23]  Inger Ekman,et al.  Reasons for seeking acute care in chronic heart failure , 2007, European journal of heart failure.

[24]  Michael Böhm,et al.  Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.

[25]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[26]  G. Filippatos,et al.  An introduction to acute heart failure syndromes: definition and classification , 2007, Heart Failure Reviews.

[27]  J. Masip.  Non-invasive ventilation , 2007, Heart Failure Reviews.

[28]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007, Atherosclerosis.

[29]  A. Cohen-Solal,et al.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.

[30]  A. Cohen-Solal,et al.  Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. , 2007, Journal of the American College of Cardiology.

[31]  J. Cleland,et al.  Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[32]  K. Swedberg,et al.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.

[33]  E. Minder,et al.  Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  C. O’loughlin,et al.  Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. , 2007, Journal of cardiac failure.

[35]  Sanjay Kalra,et al.  EXERCISE BASED REHABILITATION FOR HEART FAILURE , 2007 .

[36]  W. Stevenson,et al.  Management of atrial fibrillation in patients with heart failure. , 2007, Heart rhythm.

[37]  P. Ponikowski,et al.  Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. , 2007, Journal of the American College of Cardiology.

[38]  Stephan von Haehling,et al.  Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. , 2007, Cardiovascular research.

[39]  D. Karageorgopoulos,et al.  Etiology of anemia in patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.

[40]  M. Naughton.  The link between obstructive sleep apnea and heart failure: Underappreciated opportunity for treatment , 2006, Current heart failure reports.

[41]  P. Ponikowski,et al.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.

[42]  Eric Boersma,et al.  Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. , 2006, European heart journal.

[43]  F. Rutten,et al.  Heart failure and chronic obstructive pulmonary disease: An ignored combination? , 2006, European journal of heart failure.

[44]  D. Brutsaert.  Diastolic heart failure: perception of the syndrome and scope of the problem. , 2006, Progress in cardiovascular diseases.

[45]  A. Cohen-Solal,et al.  Clinical profile, contemporary management and one‐year mortality in patients with severe acute heart failure syndromes: The EFICA study ☆ , 2006, European journal of heart failure.

[46]  A. Hoes,et al.  Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure study , 2006, Heart.

[47]  Paul J Mills,et al.  Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. , 2006, Journal of the American College of Cardiology.

[48]  J. Rouleau,et al.  Navigating the Crossroads of Coronary Artery Disease and Heart Failure , 2006, Circulation.

[49]  G. Gazelle,et al.  A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. , 2006, Journal of cardiac failure.

[50]  Samuel Wann,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.

[51]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[52]  K. Dimopoulos,et al.  Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. , 2006, European heart journal.

[53]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[54]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[55]  J. Daubert,et al.  Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. , 2006, European heart journal.

[56]  S. Katz,et al.  Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options , 2006, Circulation.

[57]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[58]  G. D. De Keulenaer,et al.  Diastolic heart failure: a myth. , 2006, Current opinion in cardiology.

[59]  G. Filippatos,et al.  Prognosis and therapy approaches of cardiac cachexia , 2006, Current opinion in cardiology.

[60]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[61]  J. Moran,et al.  Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis , 2006, The Lancet.

[62]  M. Picard,et al.  NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. , 2006, European heart journal.

[63]  D. Thompson,et al.  Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes. , 2006, European heart journal.

[64]  P. Ponikowski,et al.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia , 2006 .

[65]  N. Freemantle,et al.  Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVE , 2006, European journal of heart failure.

[66]  C. Yancy,et al.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.

[67]  R. Fernandez,et al.  Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. , 2005, JAMA.

[68]  Andrea Giordano,et al.  Sleep and Exertional Periodic Breathing in Chronic Heart Failure: Prognostic Importance and Interdependence , 2005, Circulation.

[69]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[70]  M. Pfeffer,et al.  Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial , 2005, The Lancet.

[71]  Salim Yusuf,et al.  Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis , 2005, European journal of heart failure.

[72]  M. Cazzola,et al.  Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. , 2005, European heart journal.

[73]  L. Tavazzi,et al.  Nationwide survey on acute heart failure in cardiology ward services in Italy. , 2005, European heart journal.

[74]  C. O’loughlin,et al.  Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? , 2005, European journal of heart failure.

[75]  M. Gheorghiade,et al.  Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.

[76]  F. Rutten,et al.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.

[77]  L. Stevenson,et al.  Ventricular assist devices for durable support. , 2005, Circulation.

[78]  R. McKelvie,et al.  Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice , 2005, European journal of heart failure.

[79]  A. Cohen-Solal,et al.  Executive summary of the Position Paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology (ESC): core components of cardiac rehabilitation in chronic heart failure , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[80]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[81]  E. Barrett-Connor,et al.  Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). , 2005, The American journal of cardiology.

[82]  M. Egred,et al.  Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. , 2005, QJM : monthly journal of the Association of Physicians.

[83]  A. Rigby,et al.  Effect of a community heart failure clinic on uptake of β blockers by patients with obstructive airways disease and heart failure , 2005, Heart.

[84]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[85]  P. Poole‐Wilson,et al.  Symptoms in patients with heart failure are prognostic predictors: insights from COMET. , 2005, Journal of cardiac failure.

[86]  W. Peacock.  Morphine for Acute Decompensated Heart Failure: Valuable Adjunct or a Historical Remnant? , 2005 .

[87]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[88]  William T. Abraham,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis , 2005 .

[89]  Simon Stewart,et al.  Financial aspects of heart failure programs of care , 2005, European journal of heart failure.

[90]  J. McMurray,et al.  How much responsibility should heart failure nurses take? , 2005, European journal of heart failure.

[91]  A. Strömberg.  The crucial role of patient education in heart failure , 2005, European journal of heart failure.

[92]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[93]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[94]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[95]  R. Cody,et al.  Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure , 2005, Circulation.

[96]  D. J. Veldhuisen,et al.  Non‐compliance in patients with heart failure; how can we manage it? , 2005, European journal of heart failure.

[97]  S. Marsch,et al.  Use of B-type natriuretic peptide for the management of women with dyspnea. , 2004, The American journal of cardiology.

[98]  Akshay S. Desai,et al.  Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials , 2004 .

[99]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[100]  M. Pfeffer,et al.  Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? , 2004, Circulation.

[101]  Ralph D'Agostino,et al.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.

[102]  Warren J Manning,et al.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[103]  U. Elkayam,et al.  Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations , 2004, Journal of cardiovascular pharmacology and therapeutics.

[104]  C. O'connor,et al.  Anemia as a risk factor and therapeutic target in heart failure. , 2004, Journal of the American College of Cardiology.

[105]  A. Khasnis,et al.  Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy , 2004 .

[106]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[107]  A. Laupacis,et al.  Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study , 2004 .

[108]  C. Gullion,et al.  The incidence of congestive heart failure in type 2 diabetes: an update. , 2004, Diabetes care.

[109]  P A Poole-Wilson,et al.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. , 2004, American heart journal.

[110]  D. Renlund,et al.  Consensus statement: Palliative and supportive care in advanced heart failure. , 2004, Journal of cardiac failure.

[111]  N. Freemantle,et al.  Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.

[112]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[113]  T. Marwick,et al.  Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. , 2004, The American journal of medicine.

[114]  G. Guyatt,et al.  Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. , 2004, Journal of cardiac failure.

[115]  N. Lamblin,et al.  Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. , 2004, European heart journal.

[116]  A. Camm,et al.  Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification , 2004, Circulation.

[117]  W. Gaasch,et al.  Left ventricular diastolic dysfunction and diastolic heart failure. , 2004, Annual review of medicine.

[118]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[119]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[120]  M. Pfeffer,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.

[121]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[122]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[123]  D. Levy,et al.  Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community , 2003, Circulation.

[124]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[125]  A. Strömberg,et al.  Development and testing of the European Heart Failure Self‐Care Behaviour Scale , 2003, European journal of heart failure.

[126]  L. Levin,et al.  Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. , 2003, European heart journal.

[127]  I. Squire,et al.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001 , 2003, Heart.

[128]  F. Morady,et al.  Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. , 2003, Journal of the American College of Cardiology.

[129]  E. Wouters,et al.  Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. , 2003, Chest.

[130]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[131]  John Mullooly,et al.  Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. , 2003, The New England journal of medicine.

[132]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[133]  Christopher M O'Connor,et al.  Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.

[134]  K. Swedberg,et al.  Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. , 2003, European heart journal.

[135]  S. Czajkowski,et al.  The effect of digoxin on the quality of life in patients with heart failure. , 2003, Journal of cardiac failure.

[136]  C. Lang,et al.  Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.

[137]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[138]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[139]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[140]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[141]  M. Metra,et al.  Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. , 2002, Journal of the American College of Cardiology.

[142]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[143]  Simon Capewell,et al.  The current cost of heart failure to the National Health Service in the UK , 2002, European journal of heart failure.

[144]  M. Lauer,et al.  Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. , 2002, Journal of the American College of Cardiology.

[145]  K. Kuck,et al.  Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) , 2002, Circulation.

[146]  E. Sacanella,et al.  The Effect of Controlled Drinking in Alcoholic Cardiomyopathy , 2002, Annals of Internal Medicine.

[147]  P. Poole‐Wilson,et al.  Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. , 2002, International journal of cardiology.

[148]  Harlan M Krumholz,et al.  Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. , 2002, Journal of the American College of Cardiology.

[149]  W. Cherng,et al.  EFFECT OF VERAPAMIL IN ELDERLY PATIENTS WITH LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AS A CAUSE OF CONGESTIVE HEART FAILURE , 2002, International journal of clinical practice.

[150]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[151]  M. Bristow,et al.  Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. , 2001, International journal of cardiology.

[152]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[153]  M. Drazner,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[154]  S Capewell,et al.  More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.

[155]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[156]  S. Yusuf,et al.  Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[157]  P. Poole‐Wilson,et al.  Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.

[158]  H. Galley.  Renal-dose dopamine: will the message now get through? , 2000, The Lancet.

[159]  K. Dracup,et al.  Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions among veterans. , 2000, The American journal of cardiology.

[160]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[161]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[162]  J. McMurray,et al.  Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive study , 2000, BMJ : British Medical Journal.

[163]  J. McMurray,et al.  The acute vascular effects of frusemide in heart failure. , 2000, British journal of clinical pharmacology.

[164]  K. Dracup,et al.  A closer look at compliance research in heart failure patients in the last decade. , 2000, Progress in cardiovascular nursing.

[165]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[166]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[167]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[168]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[169]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[170]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[171]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[172]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[173]  Simon Stewart,et al.  Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study , 1999, The Lancet.

[174]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[175]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[176]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[177]  K. Bailey,et al.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period. , 1999, Archives of internal medicine.

[178]  P. Presbitero,et al.  Eisenmenger syndrome. Factors relating to deterioration and death. , 1998, European heart journal.

[179]  J. McMurray,et al.  Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. , 1998, European heart journal.

[180]  M. Flather,et al.  Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial. , 1998, European heart journal.

[181]  Y. Moshkovitz,et al.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.

[182]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[183]  A. Philip,et al.  History, definition, and classification of heart failure , 1997 .

[184]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[185]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[186]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[187]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[188]  D E Grobbee,et al.  The epidemiology of heart failure. , 1997, European heart journal.

[189]  P. Poole‐Wilson,et al.  Exercise limitation in chronic heart failure: central role of the periphery. , 1996, Journal of the American College of Cardiology.

[190]  P. Poole‐Wilson,et al.  Role of skeletal muscle in the syndrome of chronic heart failure. , 1996, Journal of molecular and cellular cardiology.

[191]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[192]  R. Hershberger,et al.  Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. , 1995, Chest.

[193]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[194]  K. Kuck,et al.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). , 1994, American heart journal.

[195]  K. Channer,et al.  Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.

[196]  P. Poole‐Wilson,et al.  Relation of pathophysiologic mechanisms to outcome in heart failure. , 1993, Journal of the American College of Cardiology.

[197]  J. Cohn,et al.  Effect of Enalapril, Hydralazine Plus Isosorbide Dinitrate, and Prazosin on Hospitalization in Patients With Chronic Congestive Heart Failure , 1993, Circulation.

[198]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[199]  D. Mancini,et al.  Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure , 1993, Circulation.

[200]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[201]  K. Hammermeister,et al.  Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1992, The New England journal of medicine.

[202]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[203]  J. Remes,et al.  Validity of clinical diagnosis of heart failure in primary health care. , 1991, European heart journal.

[204]  H. Black,et al.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. , 1990, The American journal of cardiology.

[205]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[206]  M. A. Spiteri,et al.  RELIABILITY OF ELICITING PHYSICAL SIGNS IN EXAMINATION OF THE CHEST , 1988, The Lancet.

[207]  J. Hoffman,et al.  Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. , 1987, Chest.

[208]  T. Hutchinson,et al.  Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. , 1987, Chest.

[209]  P. Poole‐Wilson,et al.  Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. , 1986, British heart journal.

[210]  G. Diamond,et al.  Correlative classification of clinical and hemodynamic function after acute myocardial infarction. , 1977, The American journal of cardiology.

[211]  A. DeMaria,et al.  Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. , 1976, The American journal of medicine.

[212]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[213]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[214]  E. H. Skinner,et al.  Diseases of the Heart , 1936, The Indian Medical Gazette.

[215]  M. Volpe,et al.  [The progression from hypertension to congestive heart failure]. , 2011, Recenti progressi in medicina.

[216]  D. Muthu,et al.  Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure , 2009 .

[217]  M. Cheitlin,et al.  Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study , 2008 .

[218]  S. Jelić,et al.  Obstructive Pulmonary Disease and Chronic Heart Failure Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic , 2008 .

[219]  S. Werns.  Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure , 2008 .

[220]  G. D. De Keulenaer,et al.  Diastolic heart failure: a separate disease or selection bias? , 2007, Progress in cardiovascular diseases.

[221]  P. Box.  Characteristics,outcomes,and predictors of 1-year mortality in patients hospitalized for acute heart failure , 2007 .

[222]  Alan S Maisel,et al.  Cardiac biomarkers: a contemporary status report , 2006, Nature Clinical Practice Cardiovascular Medicine.

[223]  D. Sin,et al.  Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. , 2005, Proceedings of the American Thoracic Society.

[224]  E. Salpeter,et al.  Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.

[225]  K. Swedberg,et al.  Expert consensus document on beta-adrenergic receptor blockers. , 2004, European heart journal.

[226]  G. Aurigemma,et al.  Clinical practice. Diastolic heart failure. , 2004, The New England journal of medicine.

[227]  A. Kocheril,et al.  Intravenous Vasodilator Therapy in Congestive Heart Failure , 2003, Drugs & aging.

[228]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[229]  Z. Rumboldt,et al.  Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. , 1998, International journal of clinical pharmacology research.

[230]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[231]  T. MacDonald,et al.  Echocardiography in chronic heart failure in the community. , 1993, The Quarterly journal of medicine.